Severe acute otitis media and mastoiditis caused by group A beta‐hemolytic streptococcus

Abstract Objective To describe the characteristics, diagnostics, treatment, and outcome of severe acute otitis media (AOM) and acute mastoiditis (AM) caused by group A beta‐hemolytic streptococcus (GAS). Study design A retrospective cohort study. Methods The yearly incidence of inpatient care‐needin...

Full description

Bibliographic Details
Main Authors: Juha T. Laakso, Valtteri Rissanen, Eeva Ruotsalainen, Jarkko Korpi, Anu Laulajainen‐Hongisto, Ville Sivonen, Saku T. Sinkkonen
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Laryngoscope Investigative Otolaryngology
Subjects:
Online Access:https://doi.org/10.1002/lio2.659
_version_ 1819179170920398848
author Juha T. Laakso
Valtteri Rissanen
Eeva Ruotsalainen
Jarkko Korpi
Anu Laulajainen‐Hongisto
Ville Sivonen
Saku T. Sinkkonen
author_facet Juha T. Laakso
Valtteri Rissanen
Eeva Ruotsalainen
Jarkko Korpi
Anu Laulajainen‐Hongisto
Ville Sivonen
Saku T. Sinkkonen
author_sort Juha T. Laakso
collection DOAJ
description Abstract Objective To describe the characteristics, diagnostics, treatment, and outcome of severe acute otitis media (AOM) and acute mastoiditis (AM) caused by group A beta‐hemolytic streptococcus (GAS). Study design A retrospective cohort study. Methods The yearly incidence of inpatient care‐needing GAS AOM/AM patients in our hospital catchment area between 2002 and 2018 was investigated. A detailed analysis was performed for cases treated during the last GAS epidemic in 2017‐2018. Anamnesis, signs and symptoms, pure‐tone audiometry results, treatment, complications, and outcome were collected from medical charts. Patients responded to an otology‐specific health‐related quality of life survey (EOS‐16) 1.5 to 3 years after their treatment. Results The number of GAS infections peaks at approximately 7‐year intervals. During 2017 and 2018, altogether 37 patients (29 adults and 8 children) were hospitalized due to GAS AOM/AM. AM was diagnosed in 14 (38%) patients. The disease progression was typically very rapid. At presentation, all patients had severe ear pain, 68% tympanic membrane perforation and discharge, 43% fever, and 43% vertigo. In pure‐tone audiometry, there was usually a marked mixed hearing loss at presentation. There was a significant recovery in both air and bone conduction thresholds; the pure tone average improvement from presentation was 32.3 ± 14.8 dB. Rapid strep tests (RST) proved to be more sensitive than bacterial culture in identifying GAS as a cause of AOM/AM. Conclusion GAS AOM/AM has a rapid onset. Hearing loss usually includes a sensorineural component, which is usually reversible with adequate treatment. RST seems to be useful in detecting GAS from middle ear discharge. Level of Evidence 4.
first_indexed 2024-12-22T21:54:12Z
format Article
id doaj.art-314957307343498ebd84b7ebaef8f94f
institution Directory Open Access Journal
issn 2378-8038
language English
last_indexed 2024-12-22T21:54:12Z
publishDate 2021-10-01
publisher Wiley
record_format Article
series Laryngoscope Investigative Otolaryngology
spelling doaj.art-314957307343498ebd84b7ebaef8f94f2022-12-21T18:11:17ZengWileyLaryngoscope Investigative Otolaryngology2378-80382021-10-01651158116610.1002/lio2.659Severe acute otitis media and mastoiditis caused by group A beta‐hemolytic streptococcusJuha T. Laakso0Valtteri Rissanen1Eeva Ruotsalainen2Jarkko Korpi3Anu Laulajainen‐Hongisto4Ville Sivonen5Saku T. Sinkkonen6Department of Otorhinolaryngology—Head and Neck Surgery, Head and Neck Center Helsinki University Hospital and University of Helsinki Helsinki FinlandDepartment of Otorhinolaryngology—Head and Neck Surgery, Head and Neck Center Helsinki University Hospital and University of Helsinki Helsinki FinlandDivision of Infectious Diseases, Department of Medicine Helsinki University Hospital and University of Helsinki Helsinki FinlandDepartment of Otorhinolaryngology—Head and Neck Surgery, Head and Neck Center Helsinki University Hospital and University of Helsinki Helsinki FinlandDepartment of Otorhinolaryngology—Head and Neck Surgery, Head and Neck Center Helsinki University Hospital and University of Helsinki Helsinki FinlandDepartment of Otorhinolaryngology—Head and Neck Surgery, Head and Neck Center Helsinki University Hospital and University of Helsinki Helsinki FinlandDepartment of Otorhinolaryngology—Head and Neck Surgery, Head and Neck Center Helsinki University Hospital and University of Helsinki Helsinki FinlandAbstract Objective To describe the characteristics, diagnostics, treatment, and outcome of severe acute otitis media (AOM) and acute mastoiditis (AM) caused by group A beta‐hemolytic streptococcus (GAS). Study design A retrospective cohort study. Methods The yearly incidence of inpatient care‐needing GAS AOM/AM patients in our hospital catchment area between 2002 and 2018 was investigated. A detailed analysis was performed for cases treated during the last GAS epidemic in 2017‐2018. Anamnesis, signs and symptoms, pure‐tone audiometry results, treatment, complications, and outcome were collected from medical charts. Patients responded to an otology‐specific health‐related quality of life survey (EOS‐16) 1.5 to 3 years after their treatment. Results The number of GAS infections peaks at approximately 7‐year intervals. During 2017 and 2018, altogether 37 patients (29 adults and 8 children) were hospitalized due to GAS AOM/AM. AM was diagnosed in 14 (38%) patients. The disease progression was typically very rapid. At presentation, all patients had severe ear pain, 68% tympanic membrane perforation and discharge, 43% fever, and 43% vertigo. In pure‐tone audiometry, there was usually a marked mixed hearing loss at presentation. There was a significant recovery in both air and bone conduction thresholds; the pure tone average improvement from presentation was 32.3 ± 14.8 dB. Rapid strep tests (RST) proved to be more sensitive than bacterial culture in identifying GAS as a cause of AOM/AM. Conclusion GAS AOM/AM has a rapid onset. Hearing loss usually includes a sensorineural component, which is usually reversible with adequate treatment. RST seems to be useful in detecting GAS from middle ear discharge. Level of Evidence 4.https://doi.org/10.1002/lio2.659acute mastoiditisacute otitis mediagroup A beta‐hemolytic streptococcushealth‐related quality of lifeStreptococcus pyogenes
spellingShingle Juha T. Laakso
Valtteri Rissanen
Eeva Ruotsalainen
Jarkko Korpi
Anu Laulajainen‐Hongisto
Ville Sivonen
Saku T. Sinkkonen
Severe acute otitis media and mastoiditis caused by group A beta‐hemolytic streptococcus
Laryngoscope Investigative Otolaryngology
acute mastoiditis
acute otitis media
group A beta‐hemolytic streptococcus
health‐related quality of life
Streptococcus pyogenes
title Severe acute otitis media and mastoiditis caused by group A beta‐hemolytic streptococcus
title_full Severe acute otitis media and mastoiditis caused by group A beta‐hemolytic streptococcus
title_fullStr Severe acute otitis media and mastoiditis caused by group A beta‐hemolytic streptococcus
title_full_unstemmed Severe acute otitis media and mastoiditis caused by group A beta‐hemolytic streptococcus
title_short Severe acute otitis media and mastoiditis caused by group A beta‐hemolytic streptococcus
title_sort severe acute otitis media and mastoiditis caused by group a beta hemolytic streptococcus
topic acute mastoiditis
acute otitis media
group A beta‐hemolytic streptococcus
health‐related quality of life
Streptococcus pyogenes
url https://doi.org/10.1002/lio2.659
work_keys_str_mv AT juhatlaakso severeacuteotitismediaandmastoiditiscausedbygroupabetahemolyticstreptococcus
AT valtteririssanen severeacuteotitismediaandmastoiditiscausedbygroupabetahemolyticstreptococcus
AT eevaruotsalainen severeacuteotitismediaandmastoiditiscausedbygroupabetahemolyticstreptococcus
AT jarkkokorpi severeacuteotitismediaandmastoiditiscausedbygroupabetahemolyticstreptococcus
AT anulaulajainenhongisto severeacuteotitismediaandmastoiditiscausedbygroupabetahemolyticstreptococcus
AT villesivonen severeacuteotitismediaandmastoiditiscausedbygroupabetahemolyticstreptococcus
AT sakutsinkkonen severeacuteotitismediaandmastoiditiscausedbygroupabetahemolyticstreptococcus